Help | RSS Feed



Yumanity Therapeutics, Inc. (NASD:YMTX) Seasonal Chart

YMTX Relative to the S&P 500
YMTX Relative to the S&P 500

YMTX Relative to the Sector
YMTX Relative to the Sector

Monthly Seasonal Yumanity Therapeutics, Inc. (NASD:YMTX)

Seasonal Chart Analysis

Analysis of the Yumanity Therapeutics, Inc. (NASD:YMTX) seasonal charts above shows that a Buy Date of October 15 and a Sell Date of January 9 has resulted in a geometric average return of 61.92% above the benchmark rate of the S&P 500 Total Return Index over the past 5 years. This seasonal timeframe has shown positive results compared to the benchmark in 4 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 5 years by an average of 126.99% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 5 years of data is available for shares of YMTX, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company’s lead program, YTX-7739, is in phase 1 clinical development for Parkinson’s disease.

To download YMTX seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z